Managing clinical conditions: Acanthamoeba

Article

Paul Karpecki, OD, FAAO, and Jill Autry, OD, RPh, shared Acanthamoeba management pearls with attendees at the American Optometric Association’s Optometry’s Meeting.

 

Philadelphia-Paul Karpecki, OD, FAAO, and Jill Autry, OD, RPh, shared clinical management pearls with attendees at the American Optometric Association’s Optometry’s Meeting.

This condition is more common in soft common contact lens wearers-75 to 90 percent of cases.

“Acanthamoeba presentation can mimic herpes simplex," says Dr. Karpecki.

“These patients are in a lot of pain, says Dr. Autry. “The corneal nerves are very inflamed.”

“Treatment is essentially pool chemicals we're throwing into the eye,” says Dr. Karpecki.

The hallmark is gelatinous presentation with disproportionate pain.

Pharmaceutical treatment includes:

• Biguanides

• Diamidines

• Antifungals

• Miconoazole, keraconozale

• Aminoglycosides

• Neomycin

“The only thing to prevent scarring is steroids,” says Dr. Karpecki.

Treatment plan includes:

• Epithelial debridement

• Pain management

• Cycloplegic, opiod, and cautious addition of steroidsODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.